Company intelligence / Profile preview

Genesystem

Yuseong-gu, Daejeon, South Koreagenesystem.co.kr ↗

Ownership: Private
Development stage: Commercial

Overview

Genesystem has commercialized rapid molecular testing platforms using proprietary ultra-fast PCR and biochip technologies. Their solutions are deployed for point-of-care diagnostics in human health, veterinary medicine, and food safety. The company continues to develop high-multiplex POCT systems with expanded biomarker coverage.

Therapeutic areas: OtherInfectious Diseases
Modalities: Device (PCR-based diagnostic device)Molecular diagnostics platform technology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Genesystem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genesystem.

Explore the full profile